Research Solutions (NASDAQ: RSSS) CRO receives 80,000-share restricted stock grant

Rhea-AI Filing Summary

Cohen Sefton reported acquisition or exercise transactions in this Form 4 filing.

Research Solutions, Inc. Chief Revenue Officer Cohen Sefton received a grant of 80,000 shares of restricted common stock valued at $2.29 per share as equity compensation. One‑third of these restricted stock awards vest on March 18, 2027, with the remainder vesting quarterly beginning March 31, 2027. Following this award, Sefton directly holds 359,933 shares of common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Cohen Sefton

Role Chief Revenue Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	80,000	$2.29	$183K

Holdings After Transaction: Common Stock — 359,933 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 80,000 shares Grant value per share: $2.29 per share Post-transaction holdings: 359,933 shares +2 more

5 metrics

Restricted stock grant 80,000 shares Grant of restricted common stock to CRO Cohen Sefton

Grant value per share $2.29 per share Value used for the 80,000-share restricted stock award

Post-transaction holdings 359,933 shares Total common shares directly held by Cohen Sefton after grant

Initial vesting date March 18, 2027 One-third of the restricted stock awards vest on this date

Quarterly vesting schedule 1/12 each quarter Remaining RSAs vest quarterly from March 31, 2027 until fully vested

Key Terms

restricted stock, RSAs, vest, Chief Revenue Officer

4 terms

restricted stock financial

"Represents a grant of shares of restricted stock ("RSAs")."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

RSAs financial

"Represents a grant of shares of restricted stock ("RSAs")."

vest financial

"1/3rd of the RSAs vest on March 18, 2027 and 1/12th of the RSAs vest on the last day of each quarter"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Chief Revenue Officer financial

"Cohen Sefton is identified as Chief Revenue Officer."

A chief revenue officer is a top executive responsible for overseeing all aspects of generating income for a company, including sales, marketing, and customer relationships. They develop strategies to attract and retain customers, much like a coach guiding a team to score more points. Investors pay attention to this role because it directly influences the company's growth and profitability.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cohen Sefton

(Last) (First) (Middle)

C/O RESEARCH SOLUTIONS, INC.

10624 S. EASTERN AVE, SUITE A-614

(Street)

HENDERSON NEVADA 89052

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Research Solutions, Inc. [ RSSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Revenue Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/18/2026		A		80,000(1)	A	$2.29	359,933	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on March 18, 2027 and 1/12th of the RSAs vest on the last day of each quarter beginning March 31, 2027 until fully vested.

	/s/ David Kutil, Attorney-in-Fact	05/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Research Solutions (RSSS) report for Cohen Sefton?

Research Solutions reported that Chief Revenue Officer Cohen Sefton received a grant of 80,000 shares of restricted common stock. The award is compensation, not an open‑market purchase, and increases his direct holdings to 359,933 shares of common stock after the transaction.

At what price were Cohen Sefton’s restricted shares in Research Solutions (RSSS) valued?

Cohen Sefton’s 80,000 restricted shares were valued at $2.29 per share. This price reflects the grant value used for the award and helps indicate the notional dollar size of this equity compensation in Research Solutions stock.

How do Cohen Sefton’s restricted stock awards in RSSS vest over time?

One‑third of Cohen Sefton’s restricted stock awards vest on March 18, 2027. The remaining two‑thirds vest in equal 1/12th installments on the last day of each quarter, starting March 31, 2027, until all 80,000 granted shares are fully vested.

How many Research Solutions (RSSS) shares does Cohen Sefton own after this Form 4 transaction?

After the reported grant, Cohen Sefton directly holds 359,933 shares of Research Solutions common stock. This total includes the newly granted 80,000 restricted shares, which will vest over time according to the specified vesting schedule in the filing footnote.

Is Cohen Sefton’s Research Solutions (RSSS) transaction a market purchase or a compensation grant?

The transaction is a compensation grant of restricted stock awards, not a market purchase. The Form 4 identifies it with code “A” for grant or award, and a footnote clarifies it represents restricted stock with time‑based vesting conditions.

What role does Cohen Sefton hold at Research Solutions (RSSS) in this Form 4 filing?

Cohen Sefton is identified as Chief Revenue Officer of Research Solutions. The reported grant of 80,000 restricted shares reflects part of his equity‑based compensation as a senior executive, aligning his interests with the company’s long‑term stock performance.